Literature DB >> 7778896

Kinetics of conversion of Neisseria gonorrhoeae to resistance to complement by cytidine 5'-monophospho-N-acetyl neuraminic acid.

J P Emond1, A Dublanchet, M Goldner.   

Abstract

Freshly isolated gonococci upon subculture are readily lysed by normal human serum although a few strains remain inherently resistant to the complement activity. The sensitive gonococci can be converted to serum resistance by incubation with a host derived factor referred to as cytidine 5'-monophospho-N-acetylneuraminic acid (CMP-NANA). These gonococci resist complement mediated killing due to their sialylation of an epitope structure on a component of lipo-oligosaccharide (LOS). In the present study, the kinetics of conversion to serum resistance by the action of sialyltransferase (STase) in Neisseria gonorrhoeae was followed with very low concentrations of CMP-NANA. This conversion could not be perceived at 2 x 10(-3) nmol.ml-1 but was fully attainable from 8 x 10(-3) to 2 x 10(-2) nmol.ml-1 CMP-NANA. When pretreated up to 100 min in presence of the very low concentration of 2 x 10(-3) nmol.ml-1, a potentiating effect on the conversion of gonococci by 2 x 10(-2) nmol.ml-1 was observed in relation to the time of preincubation. This action was abolished after exposure to a subinhibitory concentration of chloramphenicol (0.5 microgram.ml-1). The gonococci recovered their ability to convert to serum resistance following adequate washing. The potential for increase in STase activity should be of interest for understanding the conversion from a serum sensitive to a serum resistance state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7778896     DOI: 10.1007/bf00873691

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  11 in total

Review 1.  Pathogenicity and the microbe in vivo. The 1989 Fred Griffith Review Lecture.

Authors:  H Smith
Journal:  J Gen Microbiol       Date:  1990-03

2.  Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction.

Authors:  E C Tramont; J C Sadoff; M S Artenstein
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

3.  Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid.

Authors:  N J Parsons; J R Andrade; P V Patel; J A Cole; H Smith
Journal:  Microb Pathog       Date:  1989-07       Impact factor: 3.738

4.  Effects of iron and culture filtrates on killing of Neisseria gonorrhoeae by normal human serum.

Authors:  P Norrod; R P Williams
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

5.  The sialylation of gonococcal lipopolysaccharide by host factors: a major impact on pathogenicity.

Authors:  H Smith; J A Cole; N J Parsons
Journal:  FEMS Microbiol Lett       Date:  1992-12-15       Impact factor: 2.742

6.  Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum.

Authors:  C A Nairn; J A Cole; P V Patel; N J Parsons; J E Fox; H Smith
Journal:  J Gen Microbiol       Date:  1988-12

7.  Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum.

Authors:  N J Parsons; P V Patel; E L Tan; J R Andrade; C A Nairn; M Goldner; J A Cole; H Smith
Journal:  Microb Pathog       Date:  1988-10       Impact factor: 3.738

8.  Nature and Heterogeneity of the Antigens of Neisseria gonorrhoeae Involved in the Serum Bactericidal Reaction.

Authors:  A A Glynn; M E Ward
Journal:  Infect Immun       Date:  1970-08       Impact factor: 3.441

9.  Resistance to human serum of gonococci in urethral exudates is reduced by neuraminidase.

Authors:  N J Parsons; J A Cole; H Smith
Journal:  Proc Biol Sci       Date:  1990-07-23       Impact factor: 5.349

10.  In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.

Authors:  R E Mandrell; A J Lesse; J V Sugai; M Shero; J M Griffiss; J A Cole; N J Parsons; H Smith; S A Morse; M A Apicella
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  4 in total

1.  Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.

Authors:  Sunita Gulati; Andrew Cox; Lisa A Lewis; Frank St Michael; Jianjun Li; Ryan Boden; Sanjay Ram; Peter A Rice
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

2.  Regulation of gonococcal sialyltransferase, lipooligosaccharide, and serum resistance by glucose, pyruvate, and lactate.

Authors:  D J McGee; R F Rest
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.

Authors:  Sanjay Ram; Jutamas Shaughnessy; Rosane B de Oliveira; Lisa A Lewis; Sunita Gulati; Peter A Rice
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

Review 4.  Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.

Authors:  Sanjay Ram; Jutamas Shaughnessy; Rosane B DeOliveira; Lisa A Lewis; Sunita Gulati; Peter A Rice
Journal:  Immunobiology       Date:  2016-06-01       Impact factor: 3.144

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.